|

Docetaxel+Carboplatin+trastuzumab+Parstuzumab Clinical Trials

1 actively recruiting trial

Also known as: TCbHP regimen

Pipeline

Phase 2: 1

Top Sponsors

  • Henan Cancer Hospital1

Indications

  • HER2-positive Breast Cancer1
  • Breast Cancer1
  • Cancer1

Other1 trial

Comparing the Efficacy of Nab-PH+Pyrrolitinib and TCbHP in the Neoadjuvant Treatment of HER2 Positive BC
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.